{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-23-000024","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.503951+00:00","generated_at":"2026-06-12T07:24:04.326023+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Prestige Consumer Healthcare Q1 revenue $279.3M (+0.8% YoY); reaffirms FY2024 outlook","bullets":["Revenue $279.3M, up 0.8% YoY (1.8% ex-FX); net income $53.3M, diluted EPS $1.06 vs $1.09 prior year.","North American OTC revenue $246.1M (+1.5%); International OTC $33.2M, down from $34.5M on $1.9M FX headwind.","Completed $25M share repurchase (~0.4M shares); net debt ~$1.3B, leverage ratio 3.2x.","Reaffirmed FY2024 outlook: revenue $1,135-1,140M, diluted EPS $4.27-4.32, free cash flow $240M+.","Free cash flow $46.6M in Q1 vs $57.2M prior year, impacted by working capital timing."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-23-000024","json":"https://secwatch.observer/filing/0001295947-23-000024.json","markdown":"https://secwatch.observer/filing/0001295947-23-000024.md","text":"https://secwatch.observer/filing/0001295947-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000024/0001295947-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000024/pbh-20230803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:24:04.326023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25de7c6b801bf60db458525eb659bbed20812b07","claim":"Prestige Consumer Healthcare Inc. reported the fiscal quarter ended June 30, 2023 results: revenue $279.3 million, net income $53.3 million, EPS $1.06. Guidance reaffirmed.","evidence_excerpt":"Reported revenues in the first quarter of fiscal 2024 of $279.3 million increased 0.8% from $277.1 million in the first quarter of fiscal 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000024/0001295947-23-000024-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended June 30, 2023"},{"label":"Revenue","value":"$279.3 million"},{"label":"Net income","value":"$53.3 million"},{"label":"EPS","value":"$1.06"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}